 "3 companies to consider share buyback today; six cos get nod in a month")
The board of directors of three companies, Aarti Drugs, SJVN and Unichem Laboratories will meet today to consider share buyback.
The board of directors of six companies – Orbit Exports, Pidilite Industries, eClerx Services, Aarti Industries, Lovable Lingerie and Gandhi Special Tubes – approved buyback plans aggregating nearly Rs 958 crore in the past one month.
Most of these companies announced buyback through the tender route, under which repurchases were executed using a fixed price tender offer. While a share buyback does not impact a company’s business, there is a financial impact to the extent that the cash and the number of shares in its books reduce.
The board of directors of six companies – Orbit Exports, Pidilite Industries, eClerx Services, Aarti Industries, Lovable Lingerie and Gandhi Special Tubes – approved buyback plans aggregating nearly Rs 958 crore in the past one month.
Most of these companies announced buyback through the tender route, under which repurchases were executed using a fixed price tender offer. While a share buyback does not impact a company’s business, there is a financial impact to the extent that the cash and the number of shares in its books reduce.
Since buyback reduces outstanding shares, it boosts EPS (earnings per share) and, therefore, the share price. In tender offer, the company makes an offer to buy a certain number of shares at a specific price directly from shareholders.
Buyback of equity shares by companies has hit a record high in the current financial year 2017-18 (FY18), with 32 companies acquiring shares worth Rs 486.39 billion till December 2017. In previous financial year 2016-17 (FY17), total 49 companies had acquired shares amounting to Rs 339.31 billion, the Prime Database shows.
Except Lovable Lingerie, the remaining eight stocks have outperformed the market by surging up to 42% after announcement of buyback plans. Gandhi Special Tubes soared 42%, while Aarti Industries and eClerx Services rallied 23% and 18%, respectively. Unichem Laboratories, SJVN, Aarti Drugs and Orbit Exports gained more than 5% each.
| Shares | Price | Latest | % | |
| Name | in million | in Rs | price (Rs) | Chg* |
| Gandhi Special Tubes | 0.9 | 500 | 439.45 | 42.2 |
| Aarti Ind | 0.8 | 1200 | 1162.10 | 22.5 |
| eClerx Services | 1.3 | 2000 | 1531.40 | 18.0 |
| Aarti Drugs | NA | NA | 740.00 | 16.0 |
| SJVN | NA | NA | 37.75 | 9.4 |
| Unichem Lab | NA | NA | 356.55 | 7.2 |
| Orbit Exports | 0.4 | 180 | 166.15 | 5.9 |
| Pidilite Ind | 5.0 | 1000 | 911.25 | 2.5 |
| Lovable Lingerie | 2.0 | 250 | 242.45 | 1.9 |
| * over price one day prior to share buyback annoucement | ||||
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%